Morgan Stanley Increases Molina Healthcare (MOH) Price Target to $184.00

Molina Healthcare (NYSE:MOH) had its price objective increased by stock analysts at Morgan Stanley from $178.00 to $184.00 in a research note issued on Thursday. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s price target suggests a potential upside of 36.74% from the stock’s current price.

Other analysts also recently issued reports about the company. Piper Jaffray Companies increased their price target on Molina Healthcare to $165.00 and gave the company an “overweight” rating in a research report on Wednesday, September 26th. Zacks Investment Research downgraded Molina Healthcare from a “buy” rating to a “hold” rating in a research report on Monday, October 8th. Evercore ISI assumed coverage on Molina Healthcare in a research report on Tuesday, October 9th. They set an “in-line” rating and a $158.00 price target for the company. Jefferies Financial Group downgraded Molina Healthcare from a “buy” rating to a “hold” rating and set a $152.00 price target for the company. in a research report on Friday, October 12th. They noted that the move was a valuation call. Finally, Barclays increased their price target on Molina Healthcare from $105.00 to $125.00 and gave the company an “equal weight” rating in a research report on Thursday, August 2nd. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and six have issued a buy rating to the stock. Molina Healthcare has an average rating of “Hold” and an average price target of $129.77.

Shares of Molina Healthcare stock opened at $134.56 on Thursday. The company has a market capitalization of $8.84 billion, a PE ratio of 240.29, a P/E/G ratio of 1.65 and a beta of 1.27. Molina Healthcare has a 52 week low of $64.07 and a 52 week high of $154.06. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.38 and a quick ratio of 1.38.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Tuesday, July 31st. The company reported $3.08 EPS for the quarter, topping the consensus estimate of $1.09 by $1.99. The firm had revenue of $4.88 billion during the quarter, compared to the consensus estimate of $4.67 billion. Molina Healthcare had a positive return on equity of 23.01% and a negative net margin of 0.26%. The company’s quarterly revenue was down 2.3% compared to the same quarter last year. During the same period in the prior year, the business posted ($4.01) earnings per share. On average, equities research analysts predict that Molina Healthcare will post 6.68 earnings per share for the current fiscal year.

In other Molina Healthcare news, Director Ronna Romney sold 200 shares of the stock in a transaction on Tuesday, September 4th. The stock was sold at an average price of $138.11, for a total transaction of $27,622.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Daniel Cooperman sold 943 shares of the stock in a transaction on Tuesday, August 14th. The shares were sold at an average price of $133.81, for a total value of $126,182.83. The disclosure for this sale can be found here. Over the last three months, insiders have sold 9,717 shares of company stock valued at $1,289,932. 0.65% of the stock is owned by corporate insiders.

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Aperio Group LLC grew its holdings in Molina Healthcare by 1.6% during the third quarter. Aperio Group LLC now owns 22,234 shares of the company’s stock valued at $3,306,000 after purchasing an additional 360 shares during the period. World Asset Management Inc grew its holdings in Molina Healthcare by 13.9% during the third quarter. World Asset Management Inc now owns 3,047 shares of the company’s stock valued at $453,000 after purchasing an additional 372 shares during the period. Vident Investment Advisory LLC grew its holdings in Molina Healthcare by 1.5% during the second quarter. Vident Investment Advisory LLC now owns 38,230 shares of the company’s stock valued at $3,744,000 after purchasing an additional 573 shares during the period. First Mercantile Trust Co. boosted its holdings in shares of Molina Healthcare by 22.5% in the second quarter. First Mercantile Trust Co. now owns 3,442 shares of the company’s stock worth $337,000 after acquiring an additional 632 shares during the period. Finally, Louisiana State Employees Retirement System boosted its holdings in shares of Molina Healthcare by 5.8% in the second quarter. Louisiana State Employees Retirement System now owns 12,800 shares of the company’s stock worth $1,254,000 after acquiring an additional 700 shares during the period.

About Molina Healthcare

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

Featured Article: Marijuana Stocks

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply